ADIPOQ and Insulin resistance: In CKD, elevated adiponectin levels in serum are associated with increased mortality and a higher risk of anemia, left ventricular hypertrophy, impaired bone mineralization, and, paradoxically, with an increased risk of insulin resistance and generalized inflammation [18,19,20].